J

JW (Cayman) Therapeutics Co.
2126

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
HK$2.25B
EV
HK$1.95B
Shares Outstanding
405.53M
Beta
2.10

Wall Street View

Analyst Rating
BUY
Analyst Target Price
HK$2.19
P/E 2025E
-
P/Revenue 2025E
6.50x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About JW (Cayman) Therapeutics Co. Ltd

gainify

J

JW (Cayman) Therapeutics Co. Ltd

2126

JW (Cayman) Therapeutics Co. Ltd, a clinical stage cell therapy company, engages in the research and development, manufacturing, and marketing of anti-tumor drugs in the People’s Republic of China. It offers cell-based immunotherapies, including CAR-T treatments, whic...

Sector

Healthcare

Industry

Biotechnology

CEO

Liu, Min

Employees

281

IPO Date

2020-11-03

Headquarters

Building B, 5th Floor, No. 699 Zhong Ke Road, Pudong New District, Shanghai China

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.